Sinopharm
1099.HK
#2847
Rank
โ‚น575.75 B
Marketcap
โ‚น184.50
Share price
0.60%
Change (1 day)
-11.64%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.874 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.874 Trillion. In 2025 the company made a revenue of โ‚น7.874 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.671 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.874 T2.65%
2024โ‚น7.671 T-5.1%
2023โ‚น8.084 T5.42%
2022โ‚น7.668 T-2.1%
2021โ‚น7.832 T16.85%
2020โ‚น6.703 T14.95%
2019โ‚น5.831 T21.52%
2018โ‚น4.798 T5.93%
2017โ‚น4.529 T27.22%
2016โ‚น3.560 T5.37%
2015โ‚น3.379 T9.14%
2014โ‚น3.095 T17.22%
2013โ‚น2.641 T25.94%
2012โ‚น2.097 T34.61%
2011โ‚น1.557 T55.34%
2010โ‚น1.002 T35.79%
2009โ‚น738.59 B37.56%
2008โ‚น536.93 B31.43%
2007โ‚น408.54 B40.26%
2006โ‚น291.27 B